Aquagenic Wrinkling of the Palms in a Patient with Cystic Fibrosis

Aquagenic Wrinkling of the Palms in a Patient with Cystic Fibrosis

N/A

Saved in:

Bibliographic Details
Main Authors:	Inês Aparício Martins, Miguel Santos-Coelho, Cândida Fernandes
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2025-02-01
Series:	Acta Médica Portuguesa
Subjects:	Cystic Fibrosis Cystic Fibrosis Transmembrane Conductance Regulator Hand Dermatoses Water/adverse effects
Online Access:	https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/21948
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis
by: Jaime L. Rubin, et al.
Published: (2025-07-01)

Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report
by: I. Sermet-Gaudelus, et al.
Published: (1999-01-01)

Phenotype and Genotype of Two Taiwanese Cystic Fibrosis Siblings and a Survey of Delta F508 in East Asians
by: Chao-Jen Lin, et al.
Published: (2008-12-01)

Evaluation of the Effectiveness of Using the CFTR Modulator Ivacaftor/Lumacaftor in Children with Cystic Fibrosis in the Sverdlovsk Region (Prospective Cohort Study)
by: Yuliya O. Vasenyova, et al.
Published: (2024-09-01)

India: The Last and Best Frontier for Cystic Fibrosis Newborn Screening with Perspectives on Special Challenges
by: Philip M. Farrell, et al.
Published: (2025-04-01)

Evolution of Lung Disease Studied by Computed Tomography in Adults with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor
by: Susana Hernández-Muñiz, et al.
Published: (2025-04-01)

Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation
by: Meghan E. McGarry, et al.
Published: (2025-04-01)

Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation
by: Steven J Edwards, et al.
Published: (2025-05-01)

Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosis
by: Michael P. Coughlin, et al.
Published: (2024-10-01)

Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis
by: Mathew P. Estey, et al.
Published: (2025-12-01)

Current Status of Cystic Fibrosis in Türkiye: Data from the National Registry
by: Dilber Ademhan Tural, et al.
Published: (2025-09-01)

Prevalence and Characteristics of Patients with Cystic Fibrosis-Related Diabetes in Croatia
by: Lora Stanka Kirigin Biloš, et al.
Published: (2025-05-01)

Aquagenic wrinkling of the palms: A report of two cases from a family medicine setting in Eastern Saudi Arabia and literature review
by: Maryam K. Alsoweilem, et al.
Published: (2025-01-01)

Exercise Prescription in Lung-Transplanted Cystic Fibrosis Adults
by: Melissa Orlandi, et al.
Published: (2025-06-01)

Physical development of children of the city Dnipro, patientswith cystic fibrosis
by: Kramarenko N.N., et al.
Published: (2016-12-01)

Physical development of children of the city Dnipro, patients with cystic fibrosis.
by: N. N. Kramarenko, et al.
Published: (2016-12-01)

Cystic Fibrosis and Reproductive Outcomes: The Latest Insights into Fertility and Pregnancy
by: Weronika Małagocka, et al.
Published: (2025-01-01)

Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience
by: Ayşe Şenay Şaşihüseyinoğlu, et al.
Published: (2019-08-01)

The Role of Physical Activity and Exercise in Cystic Fibrosis – A Literature Review
by: Anna Bieniasz, et al.
Published: (2025-05-01)

Quantitative ultrasound rating of liver fibrosis in children with cystic fibrosis
by: G. M. Dvoryakovskaya, et al.
Published: (2014-08-01)

Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: A cases series and literature review
by: Ammar Ahmed, et al.
Published: (2024-12-01)

A clinical case report of cystic fibrosis and liver cirrhosis in a child
by: V. A. Klymenko, et al.
Published: (2018-10-01)

How to feed a child with cystic fibrosis
by: Yu. S. Pinegina
Published: (2021-06-01)

Evolution and Prognostic Variables of Cystic Fibrosis in Children and Young Adults: A Narrative Review
by: Mădălina Andreea Donos, et al.
Published: (2025-08-01)

Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways
by: Albane Jouault, et al.
Published: (2025-01-01)

Clinical features of the course of cystic fibrosis during pregnancy and childbirth
by: A. V. Teteneva, et al.
Published: (2023-01-01)

Psychiatric morbidity and quality of life in children and adolescents with cystic fibrosis
by: Gülser Şenses-Dinç, et al.
Published: (2018-02-01)

Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling
by: Eunjin Hong, et al.
Published: (2025-03-01)

A descriptive cohort study of pregnancy and parenthood in women with cystic fibrosis
by: Aleksandra Duffy, et al.
Published: (2025-07-01)

Analysis of Ivacaftor drug approval for cystic fibrosis patients with gating mutations.
by: Nemirajaiah, S.
Published: (2021-08-01)

Cystic fibrosis treatment; small molecule modulators vs genetic therapy
by: Salma Aly Elmallah, et al.
Published: (2022-10-01)

Sex disparities in cystic fibrosis in the era of highly effective modulator treatment
by: Emma McNally, et al.
Published: (2025-05-01)

Diagnosis of cystic fibrosis with chloride meter (Sherwood M926S chloride analyzer®) and sweat test analysis system (CFΔ collection system®) compared to the Gibson Cooke method
by: Nagehan Emiralioğlu, et al.
Published: (2016-02-01)

Atypical presentation of cystic fibrosis: Obese adolescent with hypertension and pseudo-Bartter’s syndrome
by: Sovtić Aleksandar, et al.
Published: (2012-01-01)

Changing epidemiology of non-cystic fibrosis bronchiectasis
by: Semiha Bahçeci, et al.
Published: (2016-02-01)

Translation, cross-cultural adaptation, and evaluation of psychometric properties of the cystic fibrosis stigma scale
by: Victor Hugo Brito de Oliveira¹, et al.
Published: (2025-05-01)

Long term azithromycin therapy in patients with cystic fibrosis
by: Nagehan Emiralioğlu, et al.
Published: (2016-02-01)

Intact spermatogenesis in an azoospermic patient with AZFa (sY84 and sY86) microdeletion and a homozygous TG12-5T variant in CFTR
by: Yifan Sun, et al.
Published: (2025-04-01)

Treatment with Inhaled Antibiotics as One of the Measures to Combat Bacterial Resistance (Cystic Fibrosis is Used as an Example)
by: A. V. Takhtamysheva
Published: (2024-03-01)

Acne vulgaris in a 22‐year‐old cystic fibrosis patient treated with Elexacaftor‐Tezacaftor‐Ivacaftor and good clinical response to isotretinoin—A case report
by: Isabelle Pfeiffer, et al.
Published: (2024-12-01)